Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34+ cells. | J Gene Med;3(3): 219-27, 2001. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34+ cells.

Dando, J S; Aiuti, A; Deola, S; Ficara, F; Bordignon, C.

Affiliation

Dando JS; San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milan, Italy.

J Gene Med ; 3(3): 219-27, 2001.

Article in En | MEDLINE | ID: mdl-11437327

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Retroviridae / Transduction, Genetic / Hematopoietic Stem Cells / Transfection / Genetic Vectors Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: J Gene Med Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2001 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Retroviridae / Transduction, Genetic / Hematopoietic Stem Cells / Transfection / Genetic Vectors Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: J Gene Med Journal subject: BIOLOGIA MOLECULAR / GENETICA MEDICA Year: 2001 Document type: Article Affiliation country: